116 Chapter 4 Acknowledgements We wish to thank all the respondents who participated in our study. Further, we would like to express our gratitude to Pharos (the Centre of Expertise on Health Disparities), who were willing to give their comments during the development of the statement set. Funding This study was funded with supported of the LUMC medical research profile Innovation in Health Strategy and Quality of Care (IHQC), https://www.lumc.nl/research/medicalresearch-profiles/innovationhealth-strategy/. Availability of data and materials The datasets used and/or analysed during the current study is available from the corresponding author on reasonable request. Authors’ contributions All authors contributed to the design of the study and the interpretation of the data. TB and FB conducted the grey literature search. TB, FB, MC and VN created the statement set for the study. TB performed the pilot study. TB conducted the statistical analysis, supervised by FB and JE. TB conducted the post-ranking interviews. FB checked the qualitative data resulting from the post-ranking interviews. TB drafted the manuscript and FB, MC, JE and VN helped drafting and revising the manuscript. OG and MN give their critical input on the final version of the manuscript. All authors have read and approved the final version of the manuscript. Ethics approval and consent to participate Upfront, this study was approved by the Medical Research and Ethics Committee of the Leiden University Medical Centre (METC Leiden| Den Haag |Delft) (N21.040) and was conducted in accordance with the Declaration of Helsinki. All respondents were informed about the aims of the study, its voluntary nature, and anonymous data usage, before giving consent to participate. Informed consent was obtained from all respondents. Consent for publication Not applicable. Competing interests The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this study.
RkJQdWJsaXNoZXIy MTk4NDMw